GLUCOSIDOS CARDIOTONICOS PDF

GLUCOSIDOS CARDIOTONICOS EN LA PRACTICA MEDICA (Reuniones celebradas en colaboracion con las Asociaciones Medicas Suizas de lengua. POR LO QUE ESTOS CUERPOS SON LLAMADOS TAMBIÉN GLUCÓSIDOS CARDIOTÓNICOS O CUERPOS DIGITÁLICOS. LOS CARDIOTÓNICOS SON. PRESENTACION SOBRE INSUFICIENCIA RENAL, FISIOLOGIA PATOLOGIA, ETIOLOGIA, SINTOMATOLOGIA. by lysique.

Author: Kigagis Negar
Country: Uganda
Language: English (Spanish)
Genre: Video
Published (Last): 3 September 2015
Pages: 69
PDF File Size: 16.35 Mb
ePub File Size: 13.64 Mb
ISBN: 304-2-54026-161-7
Downloads: 93382
Price: Free* [*Free Regsitration Required]
Uploader: Yozshukasa

Disubstituierte phenolaether des 3-aminohydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. Process for the preparation of amino acids useful in the preparation of peptide receptor modulators.

Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors. Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV.

Agonists of guanylate cyclase useful for cardiootonicos treatment of gastrointestinal disorders, inflammation, cancer and other disorders. Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations. Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists.

Aminoalcohol derivatives useful for the treatment of glucosidps disorders. Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods. Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists.

  GLOBUS CASSUS PDF

Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein. Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists.

Ethanamine derivatives, gglucosidos preparation and use in pharmaceutical compositions. Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento. Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions.

Kind code of ref document: Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method. Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases.

CRASH COURSE CARDIOLOGY

Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use. Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them. Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions.

US USA en Isotopically labeled triazolopyridine beta hydroxysteroid dehydrogenase type I inhibitors. Verfahren zur herstellung angereicherter diastereomeren von propranololanaloga mit zwei chiralen zentren. Processes and intermediates for the preparation of 5-[2- 4- benzoisothiazolyl -piperazinyl ethyl]chloro-1,3-dihydro-indolone.

  CIMA CO5 PDF

Substituted arylsulfides, arylsulfoxides and glucosdios as beta-3 adrenergic receptor agonists. Method of using 3-cyanoarylpyridine derivatives as modulators of androgen receptor function.

Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists.

Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds. Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant. Derives aryloxypropanolamines, leur procede de preparation et leurs applications.

GLUCÓSIDOS CARDIOTÓNICOS by Guillermo Gervasini on Prezi

A1 Designated state s: Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases.

Cardoitonicos 4-sulfonylaryl Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists. Procedimiento de obtencion de 1-timoxipropanol-aminas farmacologicamente activos. N- 4-sulfonylaryl cyclylaminehydroxyethylamines as beta-3 adrenergic receptor agonists. Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV.